Effects of olanzapine on serum protein phosphorylation patterns in patients with schizophrenia


Jaros J. A. , Rahmoune H., Wesseling H., Leweke F. M. , Ozcan S., Guest P. C. , ...More

PROTEOMICS CLINICAL APPLICATIONS, vol.9, pp.907-916, 2015 (Peer-Reviewed Journal) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 9
  • Publication Date: 2015
  • Doi Number: 10.1002/prca.201400148
  • Journal Name: PROTEOMICS CLINICAL APPLICATIONS
  • Journal Indexes: Science Citation Index Expanded, Scopus
  • Page Numbers: pp.907-916
  • Keywords: Biomarker, Drug response, Monitoring, Proteomics, Serum, APOLIPOPROTEIN-A-I, VENOUS THROMBOEMBOLISM, ANTIPSYCHOTIC-DRUGS, PROTEOMIC ANALYSIS, PLASMA, BLOOD, RISK, IDENTIFICATION, EXPRESSION, CLOZAPINE

Abstract

Purpose Previous studies have shown that blood serum phosphoproteins are altered in schizophrenia patients in comparison to controls. However, it is not known whether phosphoproteins are also changed in response to treatment with antipsychotics.